Does Medicare Cover Weight Loss Drugs?

Yes. Starting July 1, 2026, eligible people with Medicare drug coverage may receive certain GLP-1 medications through a temporary program called the Medicare GLP-1 Bridge. The covered options are Foundayo tablets, Wegovy injections or tablets, and Zepbound KwikPen.
This is a limited program, not a general change to Medicare Part D coverage. Eligibility depends on your age, Medicare drug coverage, body mass index (BMI), and certain health conditions. The program also has provider requirements and a $50 copayment for a one-month supply.
What Medicare DOES Cover
The Medicare GLP-1 Bridge provides access to certain GLP-1 drugs for eligible people with Part D drug coverage. It is available nationwide, including in all states and U.S. territories.
Part D coverage may come through a standalone Medicare drug plan (PDP), a Medicare Advantage plan with drug coverage (MA-PD), a Special Needs Plan (SNP), an employer or union group waiver plan (EGWP), or the LI NET program.
Covered GLP-1 Drugs
Under the Bridge, the covered medications are:
- Foundayo: Tablet
- Wegovy: Injection or tablet
- Zepbound: KwikPen only. Single-dose Zepbound vials and pens are not covered through the program.
The program is temporary and is scheduled to run through December 31, 2027. Coverage is not automatic just because a medication is on this list. You must meet the eligibility rules, and your provider must complete the required steps.

Who May Qualify for the Medicare GLP-1 Bridge?
You must be at least 18 and meet one of the following BMI and health condition criteria when starting GLP-1 therapy:
- BMI of 35 or higher, or
- BMI of 30 or higher and at least one of these conditions: diastolic heart failure (also called heart failure with preserved ejection fraction), uncontrolled high blood pressure, or chronic kidney disease at stage 3a or higher, or
- BMI of 27 or higher and at least one of these conditions: prediabetes, a previous heart attack or stroke, or symptomatic blocked arteries in the legs or arms (peripheral artery disease).
You are not eligible for the Bridge if you already get a GLP-1 drug covered through your Part D plan. You also are not eligible for this program if you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease. Your Part D plan may still cover a GLP-1 medication for one of those conditions, depending on the plan and the drug’s covered use.
These criteria are a summary, not a decision about your individual eligibility. Your healthcare provider and the program’s authorization process determine whether the requirements are met.
Provider Requirements and Program Copayment
Your doctor or other healthcare provider must send a prescription for a covered GLP-1 drug to the pharmacy. When requested, the provider must complete prior authorization and certify that the medication is being used as part of a lifestyle program focused on diet and exercise.
If approved, you pay $50 to the pharmacy for a one-month supply, which may be 28 or 30 days depending on the drug. This copayment is separate from your regular Part D benefit. It does not count toward your annual drug plan deductible or out-of-pocket limit, and it will not appear on your Part D Explanation of Benefits or Medicare Summary Notice. Extra Help cannot lower it, and it cannot be spread across multiple months through the Medicare Prescription Payment Plan.
Prior authorization, including for refills and dose changes, is valid through December 31, 2027, unless you change GLP-1 drugs.
What Medicare Does NOT Cover
Historically, Medicare Part D has excluded prescription drugs used only for weight loss under federal rules. The GLP-1 Bridge creates a limited pathway for certain drugs and eligible people. It does not mean that all weight loss medications are covered, or that all people with Medicare qualify.
For example, drugs not included in the Bridge’s covered list are not covered through this program. Zepbound single-dose vials and pens are also excluded from Bridge coverage. The program’s eligibility conditions, provider steps, and copayment apply even when a medication is on the covered list.
The answer to “does Medicare cover Ozempic?” depends on the reason it is prescribed and the plan. Ozempic is not one of the medications listed for coverage through the Medicare GLP-1 Bridge. Separately, a Part D plan may cover a GLP-1 drug for an FDA-approved use other than weight loss, such as diabetes treatment. Coverage depends on the specific plan’s formulary, prior authorization rules, and whether the prescription is for a covered use. Weight-loss-only use remains excluded from regular Part D coverage under federal rules.

How to Check Your Medicare GLP-1 Coverage
Start by confirming what kind of Medicare drug coverage you have and asking your provider whether the program requirements apply to you. If you are checking regular Part D coverage for a GLP-1 medication prescribed for another covered condition, review your plan’s formulary and authorization rules. Those details can vary by plan.
A careful review can help clarify whether the Bridge or your regular Part D plan may apply. Neuse Consulting Group can help you review your Part D coverage and understand plan rules. Learn more about our prescription drug plan review support. You can also read our related articles on whether Medicare covers hearing aids, another area where coverage varies between Original Medicare and Medicare Advantage, and how Medicare Part D works for prescription drugs. For official program details, visit Medicare.gov’s weight loss drugs page or the CMS Medicare GLP-1 Bridge page.
Frequently Asked Questions
Does Medicare cover weight loss drugs in 2026?
Starting July 1, 2026, eligible people with Medicare drug coverage may receive Foundayo tablets, Wegovy injections or tablets, or Zepbound KwikPen through the temporary Medicare GLP-1 Bridge. Eligibility and provider requirements apply, and weight-loss-only use remains excluded from regular Part D coverage under federal rules.
How much is the Medicare GLP-1 Bridge copayment?
The copayment is $50 at the pharmacy for a one-month supply, which may be 28 or 30 days depending on the drug. It does not count toward your Part D deductible or out-of-pocket limit, and Extra Help cannot lower it.
Does Medicare cover Ozempic for weight loss?
Ozempic is not listed among the medications covered through the Medicare GLP-1 Bridge. A Part D plan may cover a GLP-1 medication for an FDA-approved use other than weight loss, such as diabetes treatment, but coverage depends on the plan’s formulary, prior authorization rules, and the covered use.
Does the Medicare GLP-1 Bridge cover Zepbound?
The Bridge covers Zepbound KwikPen only. It does not cover single-dose Zepbound vials or pens. Eligibility and provider requirements also apply.
What happens if I do not qualify for the Bridge?
You may not qualify for the Bridge if you do not meet its Part D, age, BMI, or health condition rules, or if an exclusion applies. Your regular Part D plan may separately cover a GLP-1 drug for certain covered uses, depending on your plan and the reason it is prescribed.
Get Help Reviewing Your Part D Coverage
Medicare drug coverage can be difficult to sort through, especially when a temporary program and regular plan rules may both be relevant. We take the time to review your coverage and explain what may apply to your situation, without promising an outcome.
Call 984-237-3347 or visit us at 1956 S. Main St, Wake Forest, NC 27587 to request a conversation.
Neuse Consulting Group is based in Wake Forest, North Carolina, and is licensed in 14 states (NC, SC, VA, NJ, WV, PA, NY, TN, GA, FL, OH, AZ, MI, WI).
